This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jardi, R.
Right arrow Articles by Buti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jardi, R.
Right arrow Articles by Buti, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2009, p. 485-488, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01678-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Use of the Novel INNO-LiPA Line Probe Assay for Detection of Hepatitis B Virus Variants That Confer Resistance to Entecavir Therapy{triangledown}

Rosendo Jardi,1,3* Francisco Rodriguez-Frias,1,3 David Tabernero,3 Maria Homs,3 Melanie Schaper,1 Rafael Esteban,2,3 and Maria Buti2,3

Departments of Biochemistry,1 Hepatology, Hospital Universitario Vall d'Hebron, Barcelona, Spain,2 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain3

Received 29 August 2008/ Returned for modification 8 October 2008/ Accepted 22 November 2008

A line probe assay (INNO-LiPA DR, version 3) for the detection of hepatitis B virus mutations that confer resistance to entecavir therapy was evaluated. The INNO-LiPA DR assay is a highly sensitive assay that is easily applicable for the detection and monitoring of entecavir resistance-conferring mutations and is more sensitive than sequencing for the detection of mixed sequences.


* Corresponding author. Mailing address: Servicio de Bioquímica, Hospital General Vall d'Hebrón, Paseo Valle Hebrón s/n, Barcelona 08035, Spain. Phone: 34 (93) 2746100. Fax: 34 (93) 2746831. E-mail: rjardi{at}vhebron.net

{triangledown} Published ahead of print on 3 December 2008.


Journal of Clinical Microbiology, February 2009, p. 485-488, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01678-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.